Inventor profile of:

Manuel Schmidt

City:

Berlin

Country:

Germany

Published Applications:

18

Last publication date:

2023-10-05

Top Assignees for applications by Manuel Schmidt

The entities that hold a legal rights for patent applications filed by inventor Schmidt Manuel:

Recent patent applications by Schmidt Manuel

Manuel Schmidt from Berlin, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2023-10-05
US20230310594A1
Human necessities

METHODS OF TREATING A LATENT HIV-1 INFECTION USING NON-CODING DEOXYRIBONUCLEIC ACIDS

#2 | 2021-05-27
US20210155933A1
Chemistry; metallurgy

TLR-9 AGONISTS FOR MODULATION OF TUMOR MICROENVIRONMENT

#3 | 2021-03-18
US20210079403A1
Chemistry; metallurgy

TLR-9 AGONISTS FOR MODULATION OF TUMOR MICROENVIRONMENT

#4 | 2021-01-14
US20210010003A1
Chemistry; metallurgy

Combination comprising immunostimulatory oligonucleotides

#5 | 2020-12-10
US20200385732A1
Chemistry; metallurgy

BIOMARKER FOR SMALL CELL LUNG CANCER THERAPY

#6 | 2020-07-23
US20200230234A1
Human necessities

Methods of treating a retroviral infection

#7 | 2019-10-17
US20190316134A1
Chemistry; metallurgy

Combination comprising immunostimulatory oligonucleotides

#8 | 2018-09-06
US20180251767A1
Chemistry; metallurgy

Combination comprising immunostimulatory oligonucleotides

#9 | 2016-11-22
US12300295
Chemistry; metallurgy

Multimer for immunostimulation

#10 | 2016-04-28
US20160115479A1
Chemistry; metallurgy

Predictive biomarker for cancer therapy

#11 | 2013-10-17
US20130273084A1
Chemistry; metallurgy

Use of a DNA expression construct

#12 | 2012-04-19
US20120093804A1
Chemistry; metallurgy

Concatamers for Immunemodulation

#13 | 2010-12-02
US20100303803A1
Chemistry; metallurgy

CATENATE FOR IMMUNOSTIMULATION

#14 | 2010-11-25
US20100297189A1
Human necessities

Allogeneic tumor therapeutic agent, a vaccine using allogeneic tumor cells for the therapeutic treatment of tumor diseases, and a method for the making of such a vaccine, and transfected human tumor cells for use as a vaccine

#15 | 2009-09-03
US20090220931A1
Physics

FUNCTIONAL IN VITRO IMMUNOASSAY

#16 | 2009-02-26
US20090053250A1
Chemistry; metallurgy

Immune modulating oligonucleotides in connection with chemotherapeutic measures

#17 | 2007-07-12
US20070160587A1
Human necessities

Allogeneic tumor therapeutic agent, a vaccine using allogeneic tumor cells for the therapeutic treatment of tumor diseases, and a method for the making of such a vaccine, and transfected human tumor cells for use as a vaccine

#18 | 2007-03-01
US20070049546A1
Chemistry; metallurgy

Substituted, non-coding nucleic acid molecule for therapeutic and prophylactic stimulation of the immune system in humans and higher animals

InventorID:

486300 ⎘